| Literature DB >> 29534054 |
Maryam Malmir1, Rita Serrano2, Manuela Caniça3, Beatriz Silva-Lima4, Olga Silva5.
Abstract
Abstract: Plant-based systems continue to play an essential role in healthcare, and their use by different cultures has been extensively documented. Asphodelus L. (Asphodelaceae) is a genus of 18 species and of a total of 27 species, sub-species and varieties, distributed along the Mediterranean basin, and has been traditionally used for treating several diseases particularly associated with inflammatory and infectious skin disorders. The present study aimed to provide a general review of the available literature on ethnomedical, phytochemical, and biological data related to the genus Asphodelus as a potential source of new compounds with biological activity. Considering phytochemical studies, 1,8-dihydroxyanthracene derivatives, flavonoids, phenolic acids and triterpenoids were the main classes of compounds identified in roots, leaf and seeds which were correlated with their biological activities as anti-microbial, anti-fungal, anti-parasitic, cytotoxic, anti-inflammatory or antioxidant agents.Entities:
Keywords: Asphodelus; anthracene derivatives; antimicrobial; ethnomedicine; skin diseases
Year: 2018 PMID: 29534054 PMCID: PMC5874609 DOI: 10.3390/plants7010020
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Ethnomedicinal uses of the Asphodelus species.
| Species | Part Used | Country | Traditional Uses/Application | References |
|---|---|---|---|---|
| L, R | Turkey | Peptic ulcers | [ | |
| R | Turkey | Haemorrhoids, burns, wounds and nephritis | [ | |
| NI | Cyprus, Spain | Skin diseases | [ | |
| NI | Egypt, Libya | Fungal infections | [ | |
| WP | Palestine | Dermatomucosal infections | [ | |
| FR, L, R | Egypt | Ear-ache, withering and paralysis | [ | |
| R | Palestine | Dermatomucosal infections | [ | |
| R | Egypt | Ectodermal parasites, jaundice, microbial infections and psoriasis | [ | |
| NI | Algeria | Ear-ache, eczema, colds and rheumatism | [ | |
| R | North-Africa | Inflammatory disorders | [ | |
| NI | Turkey | Anti-tumoral, diuretic and emmenagogue | [ | |
| L | India | Diuretic, inflammatory disorders and ulcers | [ | |
| L, SE | Egypt | Diuretic | [ | |
| R, SE | India | Antipyretic, diuretic, colds and hemorrhoids, inflammatory disorders, rheumatic pain, ulcers and wounds | [ | |
| SE | Pakistan | ulcers and inflammatory disorders | [ | |
| WP | India | Diuretic, inflammatory disorders, bite of bees and wasps, ulcers | [ | |
| NI | Pakistan | Diuretic | [ |
SE: Seed; L: Leaf; WP: Whole plant; FR: Fruit; R: Root; NI: Not indicated, * Asphodelus luteus L.—synonym of Asphodeline lutea was formerly included in the family Asphodelaceae.
Identified compounds reported from Asphodelus genus.
| Species | Part Used | Class | Name of Compounds | References |
|---|---|---|---|---|
| L | Flavonoids | Luteolin; apigenin | [ | |
| R | Anthraquinones | Chrysophanol; asphodelin; 10,7′-bichrysophanol | [ | |
| FL | Hexadecanoic acid (35.6%), pentacosane (17.4%), tricosane (13.4%), heptacosane (8.4%), heneicosane (4.5%), phytol (4.5%), tetracosane (3%), hexacosane (2%), hexahydrofarnesyl acetone (1.7%), tetradecanoic acid (1.4%), docosane (1.3%), nonadecane (1%) | [ | ||
| L | Amino acids | Adenosine; tryptophan; phenylalanine | [ | |
| Anthraquinones | Aloe-emodin; aloe-emodin acetate; chyrosphanol 1- | |||
| Flavonoids | Isovitexin; isoorientin; isoorientin 4′- | |||
| Phenolic acid | Chlorogenic acid | |||
| SE | Fatty acids | Butyric acid; nervoic acid | [ | |
| L | Anthraquinones | Aloe-emodin; chrysophanol | [ | |
| Flavonoid | Luteolin | [ | ||
| R | Anthraquinones | Chrysophanol; asphodelin; 10,7′-bichrysophanol | [ | |
| Fatty acids | Myristic (5.3%); palmitic (18.5%); stearic (2.1%); oleic (13.5%); linoleic (44.1%); linolenic (9.9%); arachidic (2.7%); behenic (1.2%); lignoceric (2.1%) acids | [ | ||
| Triterpenoids | β-sitosterol; β-amyrin; campesterol; stigmasterol; fucosterol | |||
| R | Anthraquinones | Asphodeline; microcorpine; aloe-emodine; chrysophanole | [ | |
| L | Anthraquinones | Aloe-emodin | [ | |
| Flavonoids | Isoorientin; luteolin; luteolin 7-glucoside | [ | ||
| R | Anthraquinones | Asphodeline; microcorpine; aloe-emodine; chrysophanole | [ | |
| L | Flavonoids | Isoorientin; luteolin; luteolin 7-glucoside | [ | |
| AP | Anthraquinones | Asphodelin; asphodelin 10′-anthrone; aloesaponarin II; aloe-emodin; chrysophanol; desoxyerythrolaccin | [ | |
| Flavonoids | Chrysoeriol; luteolin | |||
| L | Anthraquinones | Dianhydrorugulosin; aloe-emodin; chrysophanol; 1,8 hydroxy-dianthraquinone | [ | |
| R | Anthraquinones | Chrysophanol; asphodelin; 10,7′-Bichrysophanol | [ | |
| SE | Anthraquinones | Dianhydrorugulosin; aloe-emodin; chrysophanol; 1,8 hydroxy-dianthraquinone | [ | |
| Carbohydrates | Sucrose; raffinose; stachyose | [ | ||
| Fatty acids | Myristic (0.5%); palmitic (5.7%); stearic (3.6%); oleic (33.1%); linoleic (54.9%) | [ | ||
| Triterpenoids | β-sitosterol; β-amyrin | [ | ||
| L | Anthraquinones | Aloe-emodin | [ | |
| L | Anthraquinones | Aloe-emodin; chrysophanol | [ | |
| Flavonoids | Luteolin | |||
| FL | Terpenoids | Germacrene D (78.3%); germacrene B (3.9%); a-elemene (3.8%); caryophyllene (3.3%) | [ | |
| Flavonoids | Luteolin; luteolin-6- | [ | ||
| Phenolic acids | 3-O caffeoylquinic acid; 5-O caffeoylquinic acid | |||
| L | Anthraquinone | Chrysophanol, 10 (chrysophanol-7-yl)-10-Hydroxychrysophanol-9-antrone, asphodoside C, Dianhydrorugulosin; aloe-emodin | [ | |
| Flavonoids | Luteolin-6- | [ | ||
| Phenolic acids | 5-O caffeoylquinic acid; cichoric acid; cumaril exosa malic acid | [ | ||
| R | Anthraquinones | Dianhydrorugulosin; aloe-emodin; chrysophanol; asphodelin; microcarpin, 8 methoxychrysophanol; emodin; 10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone; aloesaponol-III-8-methyl ether; ramosin; aestivin, asphodosides A-E, chrysophanol dianthraquinone; 5,5′-bichrysophanol; chrysophanol-8-mono-β- | [ | |
| Arylcoumarins | Asphodelin A 4′- | [ | ||
| Carbohydrates | Raffinose; sucrose; glucose; fructose | [ | ||
| Fatty acids | Palmitic; stearic; oleic; linoleic; linolenic; arachidic; behenic; lignoceric; myristic acids | [ | ||
| Naphthalene derivatives | 2-acetyl-1,8-dimethoxy-3 methylnaphthalene; 1,6-dimethoxy-3-methyl-2-naphthoic acid | [ | ||
| Mucilage | Composed of glucose; galactose; arabinose | [ | ||
| Triterpenoids | β-sitosterol-β- | [ | ||
| SE | Anthraquinones | Aloe-emodin; chrysophanol; chrysophanol-8-mono-β- | [ | |
| Carbohydrates | Sucrose; raffinose; stachyose; melibiose | [ | ||
| Fatty acids | Myristic; palmitic; stearic; oleic; linoleic acids | |||
| Triterpenoids | β-sitosterol; β-amyrin | |||
| FL | Flavonoids | Luteolin | [ | |
| Phenolic acids | Caffeic acid; chlorogenic acid; | |||
| L | Flavonoids | Luteolin; 7- | [ | |
| R | Anthraquinone | Ramosin; (−)-10′- | [ | |
| WP | Flavonoids | Naringin, quercetin, kaemferol | [ | |
| Phenolic acids | Gallic acid, chlorogenic acid, vanilic acid, cafeic acid | |||
| AP | Flavonoids | Luteolin; luteolin-7- | [ | |
| R | Naphthalene derivatives | 1,8-dimethylnaphthalene; 2-acetyl-8-methoxy-3-methyl-1-naphthol; 2-acetyl-1,8-dimethoxy-3-methylnaphthalene | [ | |
| Triterpenoids | β-sitosterol; stigmasterol | |||
| SE | Ester | 1- | [ | |
| Fatty acids | Myristic (3.96%); palmitic (13.84%); oleic (15.60%); linoleic (62.62%); linolenic (2.60%) | [ | ||
| WP | Amino acids | Crystine; serine; glycine; proline; alanine, glycin; serine; alanine and valine in the form of protein | [ | |
| Carbohydrates | ||||
| Chromone | 2-hentriacontyl-5,7-dihydroxy-8-methyl-4 | [ | ||
| Triterpenoids | Asphorodin; asphorin A; asphorin B; β-sitosterol; β-amyrin | [ |
AP: Aerial Part; FL: Flower; FR: Fruit; L: Leaf; R: Root; SE: Seed; WP: Whole plant; NI: Not indicated; * The accepted name is Asphodelus albus subsp. delphinensis (Gren. & Godr.). ** Asphodelus luteus L.—synonym of Asphodeline lutea was formerly included in the family Asphodelaceae. *** The accepted name is Asphodelus macrocarpus subsp. rubescens.
In vitro and in vivo biological studies reported from the Asphodelus genus.
| Species | Part | Extract | Test/Assay | Result | Reference |
|---|---|---|---|---|---|
| L | Aqueous, Ethanol | In vitro anti-fungal activity ( | Ethanol extract (0.25 and 0.5 mg/mL) showed higher activity than aqueous extract (0.25 and 0.5 mg/mL) and similar activity for concentrations of 1 mg/mL. | [ | |
| In vitro antioxidant activity—β-carotene bleaching effect, metal chelating, total antioxidant activity, DPPH, ABTS, superoxide radical scavenging activity, hydroxyl radical scavenging activity, DMPD, nitric oxide scavenging activity | Aqueous extract presented higher activity in metal chelating and radical scavenging assays (DPPH, IC50 aqueous = 4.58 mg/mL and IC50 methanol = 9.54 mg/mL, superoxide, hydroxyl, DMPD) | ||||
| L | Acetone, Methanol | In vitro antioxidant activity—β-carotene, reducing power assay, DPPH, ABTS, inhibition of linoleic acid peroxidation, superoxide radical scavenging assays | Reducing power and total antioxidant activity were higher in acetone extract; free radical and superoxide radical scavenging activity were higher in methanol extract (DPPH, IC50 methanol = 0.16 mg/mL and IC50 acetone = 0.50 mg/mL) | [ | |
| L, R | Dichloromethane | In vitro cytotoxic activity—MTT assay against human lung cell cancer (A549) and prostate cell cancer (PC3) | Root: | [ | |
| R | Aqueous (decoction) | In vivo anti-inflammatory—Ethanol induced gastric ulcer model in rats | Decoction gave significant protection against the lesions | [ | |
| R | Aqueous (infusion and decoction) Diethyl ether, Ethyl acetate, Methanol | In vitro antioxidant activity—DPPH assay | Diethyl ether (IC50 = 22.46 µg/mL) have a higher scavenging activity than Ethyl acetate (IC50 = 188.90 µg/mL), both have lower activity than reference substance, rutin (7.77 µg/mL). Methanol and aqueous extract had no scavenging activity | [ | |
| In vitro cytotoxic & apoptotic activity—MCF-7 breast cancer cells-trypan blue exclusion assay, comet assay, Hoechst 33,258, propidium iodide double staining | Methanol and aqueous extracts exhibited strong cytotoxic activities. All extracts showed significant DNA damaging and apoptotic activities. | ||||
| SE | Petroleum ether | In vitro antimicrobial/fungal activity—broth microdilution method | Active against | [ | |
| WP | In vitro anti-microbial/fungal activity—well and disk diffusion method | Active against | [ | ||
| WP | Aqueous | In vitro antioxidant activity—DPPH assay | Inhibition % = 62.5 | [ | |
| NI | NI | In vitro anti-microbial/fungal activity | Positive to | [ | |
| AP | Aqueous | In vitro anti-fungal activity—Agar dilution method | Activity against | [ | |
| AP | Methanol, Petroleum Ether | In vitro anti-microbial activity—agar diffusion test; tetrazolium microplate assay (MIC) | Against MRSA isolates | [ | |
| R | Methanol | In vitro antioxidant activity—DPPH assay | IC50 (methnol)= 0.54 mg/mL, IC50 (reference, BHT) = 0.017 mg/mL | [ | |
| AP | Aqueous | In vitro anti-fungal activity—Agar dilution method | Weak activity against | [ | |
| AP | Methanol | In vitro anti-microbial activity—agar diffusion test; tetrazolium microplate assay (MIC) | Against MRSA isolates | [ | |
| FL | Aqueous, Ethanol, Methanol | In vitro antimelanogenic activity—tyrosinase inhibition (mushroom tyrosinase assay and mouse melanoma cells viability), kojic acid as positive control | Antimelanogenic activity | [ | |
| In vitro antioxidant activity—DPPH and ABTS (reference—Trolox) | Antioxidant activity | ||||
| L | Ethanol | In vitro antimicrobial/fungal activity—micro broth dilution method | Active against | [ | |
| In vitro antiviral activity (IFN-β induction)—luciferase reporter gene assay | Antiviral activity | ||||
| In vitro cytotoxicity-Cell viability of A549 cells, positive control (camptothecin) | Cytotoxicity | ||||
| L | Methanol | In vitro antimicrobial/fungal—two-fold serial dilution technique | Antimicrobial activity | [ | |
| In vitro antiviral activity—CPE inhibition assay against HSV-1 and HAV-10 | Antiviral activity | ||||
| In vitro cytotoxicity—viability assay against human tumor cell lines of the lung (A-549), colon (HCT-116), breast (MCF-7) and prostate (PC3). Cisplatin as standard | Cytotoxicity | ||||
| R | Methnol | In vitro antioxidant activity—DPPH assay | IC50 (Methnol) = 0.30 mg/mL, IC50 (reference, BHT) = 0.017 mg/mL | [ | |
| R | Methanol | In vitro anti-microbial—Disk diffusion assay | No activity against | [ | |
| WP | Aqueous, Ethanol | In vitro antioxidant activity—DPPH assay | Ethanol extract (100 µg/mL) with moderate activity (inhibition percentage—60.3%) higher than aqueous extract (100 µg/mL, inhibition percentage—49.5%) | [ | |
| In vitro cytotoxic activity—Trypan blue technique for Ehrlich Ascites Carcinoma Cells (EACC) | Weak anti-cancer activity of both extracts | ||||
| R | Aqueous, Chloroform, Ethanol, Methanol | In vivo anti-inflammatory—Arachidonic acid test (mouse ear oedema) | Arachidonic acid test: Positive activity from chloroform and ethanol extracts | [ | |
| WP | Aqueous, Methanol, Methanol 50% | In vitro antioxidant activity—DPPH assay at 35 °C and 65 °C | Aqueous extract at 65 °C had the highest inhibition percentage | [ | |
| AP | Butanol, Ethyl acetate, Methylene-chloride | In vitro anti-microbial/fungal activity—Disc diffusion method | All extracts showed antimicrobial activity, the methylene-chloride as the most active against | [ | |
| FR | Acetone, Aqueous, Benzene, Chloroform, Methanol, Petroleum ether | In vitro anti-microbial/fungal activity—Kirk-bauer disc diffusion method | Significant activity against | [ | |
| L | Acetone, Methanol | In vitro anti-microbial/fungal activity—Agar disc diffusion method | Methanol extract positive against | [ | |
| R | Methanol | In vitro antioxidant activity—DPPH, ABTS+, NO, OH, O2−, ONOO− assays, Oxidative DNA damage | Positive activity, DPPH (IC50 = 2.006 µg/mL), ABTS·+ (IC50 = 156.94 µg/mL), NO (nd), OH (IC50 = 50.13 µg/mL), O2− (IC50 = 425.92 µg/mL) and ONOO- (IC50 = 3.390 µg/mL), oxidative DNA damage: 1.85 µg/mL of extract prevented DNA damage. | [ | |
| R | Benzene, Chloroform, Ethyl acetate, Methanol, Petroleum ether | In vitro anti-microbial/fungal activity—Disc diffusion method | All extracts were active against | [ | |
| SE | Aqueous, Ethanol, Methanol, Petroleum ether | In vitro anti-microbial/fungal activity—modified Kirby Bauer disc diffusion method | Petroleum ether: no antibacterial activity | [ | |
| WP | Methanol | In vitro antimicrobial/fungal activity—disk diffusion method | Good activity against | [ | |
| WP | Aqueous | In vivo hypotensive activity—blood pressure (BP) measure after parenteral administration of aqueous extracts in rats. Acetylcholine and verapamil as positive controls in co administration with atropine | Hypotensive activity | [ | |
| In vivo diuretic activity—measure of rat urine output and urinary electrolytes. After 6 hr administration. Saline solution and furosemide as controls | Diuretic activity |
AP: Aerial Part; FL: Flower; FR: Fruit; L: Leaf; R: Root; SE: Seed; WP: Whole plant; NI: Not indicated; * Asphodelus luteus L.—synonym of Asphodeline lutea was formerly included in the family Asphodelaceae. ABTS+: 2,2′-azinobis-(3-ethylbenzothiazole-6-sulphonate) radical cation, DMPD: N,N-dimethyl-p-phenylenediamine dihydrochloride, DPPH: 2,2-diphenyl-1-picrylhydrazyl radical, NO: nitric oxide radical, O2.–: superoxide anion radical , ·OH: hydroxyl radical, ONOO-: Peroxynitrite radicals, EBOV: Ebola virus.
In vitro and in vivo biological studies reported from pure compounds isolated from Asphodelus genus.
| Species | Pure Compounds | Test/Assay | Result | Reference |
|---|---|---|---|---|
| Asphodelin A 4′- | In vitro antimicrobial/fungal activity—micro dilution assay | [ | ||
| 3-methyl anthraline, chrysophanol, and aloe-emodine | Psoriasis | Positive (patent) | [ | |
| 1,6-dimethoxy-3-methyl-2-naphthoic acid (1), asphodelin (2), chrysophanol (3), 8 methoxychrysophanol (4), emodin (5), 2-acetyl-1,8-dimethoxy-3-methylnaphthalene (6), 10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone (7), aloesaponol-III-8-methyl ether (8), ramosin (9), aestivin (10) | In vitro anti-parasitic activity | Compounds | [ | |
| In vitro cytotoxic activity-Human acute leukemia HL60 cells/human chronic leukemia 562 cells | Compounds | |||
| In vitro antimalarial activity—chloroquine sensitive & resistant strains of Plasmodium falciparum (plasmodial LDH activity) | Compound | |||
| In vitro anti-microbial/fungal activity | Compound | |||
| Methyl-1,4,5-trihydroxy-7-methyl-9,10-dioxo-9,10-dihydroanthracene-2-carboxylate (1), (1 | In vitro anti-parasitic activity | Compound | [ | |
| In vitro anti-microbial/activity | Compound | |||
| 5 Compounds, Asphodosides A–E | In vitro anti-microbial activity | Compounds | [ | |
| Asphorodin | In vitro anti-inflammatory-inhibition of lipoxigenase enzyme | Potent inhibitory activity (IC50 = 18.1 µM), Reference: baicalein (22.6 µM) | [ |